Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol-based new thiosemicarbazide and 1,3,4-thiadiazole derivatives

dc.contributor.authorAlagoz, Tenzile
dc.contributor.authorCaliskan, Fatma Gunes
dc.contributor.authorBilgicli, Hayriye Genc
dc.contributor.authorZengin, Mustafa
dc.contributor.authorSadeghi, Morteza
dc.contributor.authorTaslimi, Parham
dc.contributor.authorGülçin, İlhami
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T13:23:12Z
dc.date.created2023
dc.date.issued2023
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractA series of carvacrol-based thiosemicarbazide (3a-e) and 1,3,4-thiadiazole-2-amine (4a-e) were designed and synthesized for the first time. The structures were characterized by nuclear magnetic resonance and high resolution mass spectroscopy techniques. All compounds were examined for some metabolic enzyme activities. Results indicated that all the synthetic molecules exhibited powerful inhibitory actions against human carbonic anhydrase I and II (hCAI and II), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) enzymes compared to the standard molecules. Ki values of five novel thiosemicarbazides and five new 1,3,4-thiadiazole-2-amine derivatives (3a-e and 4a-e) for hCA I, hCA II, AChE, and BChE enzymes were obtained in the ranges 0.73-21.60, 0.42-15.08 & mu;M, 3.48-81.48, 92.61-211.40 nM, respectively. After the experimental undertaking, an extensive molecular docking analysis was conducted to scrutinize the intricate details of interactions between the ligand and the enzyme in question. The principal focus of this investigation was to appraise the potency and efficacy of the most active compound. In this context, the calculated docking scores were noted to be remarkably low, with values of -8.65, -7.97, -8.92, and -8.32 kcal/mol being recorded for hCA I, hCA II, AChE, and BChE, respectively. These observations suggest a high affinity and specificity of the studied compounds toward the enzymes, as mentioned earlier, which may pave the way for novel therapeutic interventions aimed at modulating the activity of these enzymes. Novel thiosemicarbazide and 1,3,4-thiadiazole derivatives were designed, synthesized and tested for their inhibitory activity against human carbonic anhydrase (hCA) I, hCA II, acetylcholinesterase (AChE), and butylcholinesterase (BChE). The molecular docking study identified compounds that exhibit superior efficacy regarding AChE (4e), BChE (3e), hCA I (4e), and hCA II (4e).image
dc.description.sponsorshipThis research was partly supported by the Research Fund of Sakarya University (Project Number: 2021-9-33-120). We would like to thank Sakarya University Research and Development Application and Research Center (SARGEM) for their support in the acquisition [2021-9-33-120]; Research Fund of Sakarya University; Sakarya University Research and Development Application and Research Center (SARGEM)
dc.description.sponsorshipThis research was partly supported by the Research Fund of Sakarya University (Project Number: 2021-9-33-120). We would like to thank Sakarya University Research and Development Application and Research Center (SARGEM) for their support in the acquisition of some of the mass spectra.
dc.identifier.doi10.1002/ardp.202300370
dc.identifier.issn0365-6233
dc.identifier.issn1521-4184
dc.identifier.issue12
dc.identifier.orcidGenc Bilgicli, Hayriye/0000-0001-6909-316X
dc.identifier.orcidCaliskan, Fatma/0000-0002-9772-5117
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.orcidSadeghi, Morteza/0000-0002-5027-4777
dc.identifier.pmid37743251
dc.identifier.scopus2-s2.0-85171877497
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1002/ardp.202300370
dc.identifier.urihttps://hdl.handle.net/11772/22747
dc.identifier.volume356
dc.identifier.wosWOS:001068934600001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofArchiv Der Pharmazie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzWoS_20251016
dc.subject1,3,4-Thiadiazole
dc.subjectEnzyme Inhibition
dc.subjectMolecular Docking
dc.subjectSynthesis
dc.subjectThiosemicarbazide
dc.titleSynthesis, characterization, biochemical, and molecular modeling studies of carvacrol-based new thiosemicarbazide and 1,3,4-thiadiazole derivatives
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar